「Epidemiology」の版間の差分
ナビゲーションに移動
検索に移動
Vaccipedia.admin (トーク | 投稿記録) (ページの作成:「==Self-assessment quiz== *[https://www.cdc.gov/csels/dsepd/ss1978/index.html CDC Principles of Epidemiology] *[https://www.med.soton.ac.uk/stats_eLearning/quizzes/index.h…」) |
Vaccipedia.admin (トーク | 投稿記録) |
||
235行目: | 235行目: | ||
*To mask research question/hypothesis to participants | *To mask research question/hypothesis to participants | ||
|} | |} | ||
+ | |||
+ | ==Confounding and Effect modification== | ||
+ | {{#mermaid: | ||
+ | flowchart TD | ||
+ | crude[Crude analysis] --> strata[Stratified analysis] | ||
+ | strata --> node1[[Are stratified estimates similar to each other?]] | ||
+ | node1 -- "YES, similar to each other" --> MH[Mantel-Haenszel adjusted analysis] | ||
+ | MH --> node2[[Is MH adjusted estimate similar to crude estimate?]] | ||
+ | node2 -- "YES, similar to crude" --> No([There is no Confounding nor Effect modification]) --> R1["Report crude (MH adjusted) estimate"] | ||
+ | node2 -- "NO, different from crude" --> Co([There is Confounding]) --> R2[Report MH adjusted estimate] | ||
+ | node1 -- "NO, different from each other" ----> EM([There is Effect modification]) --> R3[Report stratified estimates] | ||
+ | R2 -.-> node3[[Are all possible confounders measured<br>and all possible stratification conducted?]] | ||
+ | node3 -- "YES, rigorous" --> noR([MH adjusted estimate should be<br>closer to the true population value]) | ||
+ | node3 -- "NO, unfeasible" --> yesR([MH adjusted estimate should<br>still include residual confounding]) | ||
+ | }} |
2022年12月11日 (日) 18:02時点における版
目次
Self-assessment quiz
Disease frequency measurement
Bradford Hill Criteria for assuming causality
In terms of the association between exposure and outcome, exposure is more likely to be causal if .... | |
---|---|
1. Strength of association | the stronger the association is. |
2. Consistency | in the more varieties settings the association is observed. |
3. Specificity | the more specific the exposure is, i.e., the exposure is associated with only single outcome. |
4. Temporality | the exposure comes first and the outcome appears after the exposure |
5. Biological gradient | the more (or less) exposure is associated with more frequent outcome (exposure dose dependent). |
6. Plausibility | the mechanism between the exposure and the outcome can be explained according to biological body of knowledge. |
7. Coherence | the mechanism between the exposure and the outcome can be proven by certain medical testings. |
8. Experiment | some intervention to the exposure can change frequency and/or extent of the outcome. |
9. Analogy | another similar exposure is associated with another similar outcome. |
Classification of Bias
Major classification | Specific name | Description | Affecting design | |
---|---|---|---|---|
Selection bias | Sample is not properly representative of population | Ascertainment bias | Inappropriate definition of population | Any observational design |
Healthy worker effect | Current employees are more likely to be healthy than general population and ex-employees | Cohort, esp. historical | ||
Detection bias | Diagnostic procedures are different between case and control | Case-control | ||
Attrition bias (Loss to follow-up) |
needless to explain | Cohort Clinical trial | ||
Non-response bias | a.k.a. Healthy volunteer effect; Voluntary participants are not representative of population | Any observational design | ||
Language bias | Medical articles written in languages unfamiliar to researchers are more likely to be ignored | Meta-analysis Systematic review | ||
Publication bias | Researches with negative results are more likely to be unpublished | Meta-analysis Systematic review | ||
Information bias (Measurement bias) |
Observation is not properly conducted | Non-differential misclassification bias | Failure to properly measure exposure/outcome and inappropriate allocations of groups in the same weight for both
|
Any design |
Differential misclassification bias | Failure to properly measure exposure/outcome and inappropriate allocations of groups in different weights in-between
|
Any design | ||
|
|
Any design | ||
|
|
Any design | ||
Observer/interviewer bias | Observers/interviewers are more likely to observe/draw interviews toward exposure according to case outcome status | Any design | ||
Ecological fallacy | Ecological design | |||
Regression to the mean | Extreme observations in initial investigations will be toward true population value in later investigations | Cohort Clinical trial | ||
Hawthorne effect | Observation itself can affect outcome | Clinical trial | ||
Lead-time bias | Screening trial can diagnose outcome even in its earlier latent period which fallaciously show longer survival | Screening trial | ||
Confounding | Third factors affect both of exposure and outcome |
Confounding may occur even in RCT if randomization process is inappropriate (as systematic error) or randomly allocated groups are heterogenous by chance (as random error) |
Difference between Population and Sample
Accuracy and Precision
Accuracy |
|
---|---|
Precision |
|
Accuracy in [math]\displaystyle{ x }[/math]-axis, Precision in [math]\displaystyle{ y }[/math]-axis
*In this example, μ is sample mean, not the population mean
Precision in [math]\displaystyle{ x }[/math]-axis, Accuracy in [math]\displaystyle{ y }[/math]-axis
Tips in Case-control design
Sampling (selection bias)
Case sampling | Control sampling |
---|---|
|
|
|
|
|
|
| |
|
Measurement (Information bias)
Observer bias |
|
---|---|
Recall bias |
|